New hope for kids with hemophilia: trial tests Long-Term bleeding prevention
NCT ID NCT07285460
Summary
This study is testing a drug called fitusiran to see if it can safely and effectively prevent bleeding episodes in young boys with severe hemophilia A or B. About 85 boys aged 1 to under 12 will receive the drug for up to 3 years. The main goal is to see if fitusiran reduces the number of bleeds that need treatment compared to their current standard care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo- Site Number : 0760004
RECRUITINGSão Paulo, 05403-000, Brazil
-
Investigational Site Number : 0560002
RECRUITINGBrussels, 1020, Belgium
-
Investigational Site Number : 1240003
RECRUITINGMontreal, Quebec, H3T 1C5, Canada
-
Investigational Site Number : 3560001
RECRUITINGPune, 411004, India
-
Investigational Site Number : 3560002
RECRUITINGMumbai, 400022, India
-
Investigational Site Number : 6160002
RECRUITINGWroclaw, Lower Silesian Voivodeship, 50-556, Poland
-
Investigational Site Number : 7240001
RECRUITINGEsplugues de Llobregat, Barcelona [Barcelona], 08950, Spain
-
Investigational Site Number : 7240002
RECRUITINGMadrid, 28046, Spain
-
Investigational Site Number : 7240003
RECRUITINGZaragoza, 50009, Spain
-
Investigational Site Number : 7920001
RECRUITINGIstanbul, 34093, Turkey (Türkiye)
-
Investigational Site Number : 7920002
RECRUITINGIzmir, 35100, Turkey (Türkiye)
-
The Center for Inherited Blood Disorders- Site Number : 8400009
RECRUITINGOrange, California, 92868, United States
-
The Luskin Orthopaedic Institute for Children- Site Number : 8400013
RECRUITINGLos Angeles, California, 90007, United States
Conditions
Explore the condition pages connected to this study.